In fiscal year 2025, DongBang Medical (240550) reported revenue of 113.5 billion KRW.
Income Statement
| Year | Revenue | Op Profit | Net Income | Source |
|---|---|---|---|---|
| 2025 | 113.5 billion KRW | 17.0 billion KRW | 11.4 billion KRW | [source] |
| 2024 | 105.1 billion KRW | 15.0 billion KRW | 3.1 billion KRW | [source] |
| 2023 | 90.9 billion KRW | 16.5 billion KRW | 9.7 billion KRW | — |
| 2022 | 81.4 billion KRW | 6.1 billion KRW | 3.3 billion KRW | — |
Balance Sheet
| Year | Total Assets | Total Liabilities | Total Equity | Source |
|---|---|---|---|---|
| 2025 | 148.7 billion KRW | 36.6 billion KRW | 112.2 billion KRW | [source] |
| 2024 | 114.2 billion KRW | 45.7 billion KRW | 68.5 billion KRW | [source] |
| 2023 | — | — | — | — |
| 2022 | — | — | — | — |
Cash Flow
| Year | Operating | Investing | Financing | Source |
|---|---|---|---|---|
| 2025 | 12.0 billion KRW | -20.3 billion KRW | 24.0 billion KRW | [source] |
| 2024 | 18.5 billion KRW | -17.7 billion KRW | -230 million KRW | [source] |
| 2023 | — | — | — | — |
| 2022 | — | — | — | — |
Years without a source link are outside the DART financial API collection period.
Balance sheet figures for the relevant year were not collected.
Cash flow figures for the relevant year were not collected.